Recursion Pharmaceuticals, Inc. earnings per share and revenue

RXRX earnings per share for the last quarter are -0.53 USD whereas the estimation was -0.41 USD which accounts for -28.82% surprise. Company revenue for the same period amounts to 4.51 M USD despite the estimated figure of 15.31 M USD. Estimated earnings per share for the next quarter are -0.52 USD, and revenue is expected to reach 14.98 M USD. Also watch annual changes over time to get a bigger picture of RXRX earnings per share and revenue dynamics.